Methyl-GBB oral (Grindeks)

N/A

Report date: 2022/12/05 11:27:18
NME

Base Information

Drug NameMethyl-GBB oral (Grindeks)
Drug Alias Namemethyl-gamma-butyrobetaine oral (Grindeks)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 22 member 5 inhibitorsGamma-butyrobetaine dioxygenase inhibitors
TargetsSolute carrier family 22 member 5Gamma-butyrobetaine dioxygenase
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrindeks ASLatvian Institute Of Organic Synthesis
China Registration ClassN/A

Develop Information

Active CompaniesLatvian Institute Of Organic SynthesisGrindeks AS
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A